Ignite Creation Date:
2025-12-24 @ 7:21 PM
Ignite Modification Date:
2026-01-14 @ 5:29 PM
Study NCT ID:
NCT05470803
Status:
UNKNOWN
Last Update Posted:
2022-07-22
First Post:
2022-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Observer-blind, Cohort Randomized, Exploratory Phase 3 Study to Evaluate the Safety and Immunogenicity of Recombinant Covid-19 Vaccine, mRNA Covid-19 Vaccine and Recombinant SARS-CoV-2 Trimeric S-protein Subunit Vaccine as 4th Dose in Individuals Primed/ Boosted With Various Regimens
Sponsor:
D'Or Institute for Research and Education
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-08
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-20
First Submit QC Date:
None
Study First Post Date:
2022-07-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-21
Last Update Post Date:
2022-07-22
Last Update Post Date Type:
ACTUAL